These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2427454)

  • 1. Plasminogen activator production from murine mastocytoma cells. Dissociation of plasminogen activator and histamine production by sodium butyrate.
    Katayama I; Hashimoto K; Nishioka K
    Int Arch Allergy Appl Immunol; 1986; 81(1):42-5. PubMed ID: 2427454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of plasminogen-activator in mastocytoma cells by lymphokines.
    Kramer M; Woodbury RG; Schirrmacher V; Robinson P
    Immunobiology; 1983 Jul; 165(1):107-12. PubMed ID: 6411606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production, purification and characterization of the plasminogen activator in teratocarcinoma stem cells induced with sodium butyrate.
    Ichikawa N; Miyashita T; Nishimune Y; Matsushiro A
    Biken J; 1984 Dec; 27(4):143-51. PubMed ID: 6443174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate.
    Gross JL; Behrens DL; Mullins DE; Kornblith PL; Dexter DL
    Cancer Res; 1988 Jan; 48(2):291-6. PubMed ID: 3121170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Butyrate stimulates tissue-type plasminogen-activator synthesis in cultured human endothelial cells.
    Kooistra T; van den Berg J; Töns A; Platenburg G; Rijken DC; van den Berg E
    Biochem J; 1987 Nov; 247(3):605-12. PubMed ID: 2827633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of sodium butyrate on cyclic AMP phosphodiesterase activities in butyrate sensitive and resistant mastocytoma cells.
    Mori Y; Tanigaki Y; Yamaguchi A; Akedo H
    Biochem Biophys Res Commun; 1986 Aug; 138(3):1030-6. PubMed ID: 3019329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor cell surface expression of granulocyte-macrophage colony-stimulating factor elicits antitumor immunity and protects from tumor challenge in the P815 mouse mastocytoma tumor model.
    Soo Hoo W; Lundeen KA; Kohrumel JR; Pham NL; Brostoff SW; Bartholomew RM; Carlo DJ
    J Immunol; 1999 Jun; 162(12):7343-9. PubMed ID: 10358185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activator release from cultured murine mast cells.
    Bartholomew JS; Woolley DE
    Biochem Biophys Res Commun; 1988 Jun; 153(2):540-4. PubMed ID: 3132912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosynthesis of heparin. Effects of n-butyrate on cultured mast cells.
    Jacobsson KG; Riesenfeld J; Lindahl U
    J Biol Chem; 1985 Oct; 260(22):12154-9. PubMed ID: 3930489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sodium butyrate on the production of serotonin, histamine and glycosaminoglycans by cultured murine mastocytoma cells.
    Mori Y; Akedo H; Tanigaki Y; Tanaka KM; Okada M; Nakamura N
    Exp Cell Res; 1980 Jun; 127(2):465-70. PubMed ID: 6769688
    [No Abstract]   [Full Text] [Related]  

  • 11. Modulation of secreted plasminogen activator activity of human renal carcinoma cells by dimethylsulfoxide, butyrate and retinoate.
    Nelson NF; Cieplak W; Dacus SC; Prager MD
    Cancer Lett; 1987 Mar; 34(3):305-16. PubMed ID: 3548947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium butyrate-induced adhesion in mastocytoma cells.
    Matsuhisa T; Mori Y; Tamura H
    Biol Cell; 1984; 50(1):1-7. PubMed ID: 6234039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor beta 1 and sodium butyrate differentially modulate urokinase plasminogen activator and plasminogen activator inhibitor-1 in human breast normal and cancer cells.
    Dong-Le Bourhis X; Lambrecht V; Boilly B
    Br J Cancer; 1998; 77(3):396-403. PubMed ID: 9472634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the cellular glycosaminoglycans of cultured mastocytoma cells induced by sodium butyrate.
    Nakamura N; Mori Y; Tanigaki Y; Kojima J
    Biochim Biophys Acta; 1980 Jan; 627(1):60-70. PubMed ID: 6766327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of a cell-associated and secreted plasminogen activator by cultured rat granulosa cells.
    Knecht M
    Endocrinology; 1986 Jan; 118(1):348-53. PubMed ID: 2934243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of tranexamic acid on growth and spread of an experimental tumor model.
    Teodorczyk-Injeyan J; Falk R; Ng RW; Kellen JA
    Res Commun Chem Pathol Pharmacol; 1983 Mar; 39(3):515-8. PubMed ID: 6407075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of sodium butyrate on lymphokine production.
    Le Gros GS; Herbert AG; Watson JD
    Lymphokine Res; 1985; 4(3):221-7. PubMed ID: 3928980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of prostaglandin synthesizing activity by the treatment with sodium n-butyrate on cloned mastocytoma cells and various other tissue cell lines.
    Kawamura M; Koshihara Y; Senshu T; Murota S
    Prostaglandins; 1980 May; 19(5):659-69. PubMed ID: 6775349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the effects of various stimulatory agents on t-PA secretion by normal and malignant cell lines.
    Clarke J; Griffiths B; Melling J; Ling R; Atkinson T; Electricwala A
    Cell Biochem Funct; 1989 Oct; 7(4):283-91. PubMed ID: 2481573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Butyrate inhibits the retinoic acid-induced differentiation of F9 teratocarcinoma stem cells.
    Levine RA; Campisi J; Wang SY; Gudas LJ
    Dev Biol; 1984 Oct; 105(2):443-50. PubMed ID: 6090244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.